Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Maria Aguado

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|September 22, 2010
Safety and efficacy of moxifloxacin monotherapy for treatment of orthopedic implant-related staphylococcal infectionsRafael San Juan, Ana Garcia-Reyne, Pedro Caba, et al.
Urology|February 19, 2008
Incisional surgical site infection in kidney transplantationAntonio Ramos, Angel Asensio, Elena Muñez, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 29, 2007
Staphylococcus aureus poststernotomy mediastinitis: description of two distinct acquisition pathways with different potential preventive approachesRafael San Juan, Fernando Chaves, Maria Jesus López Gude, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 24, 2024
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with "difficult to treat" Gram-negative bacteriaCecilia Bonazzetti, Matteo Rinaldi, Federica Cosentino, et al.
The Lancet. Infectious Diseases|December 24, 2017
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trialBenoit Guery, Francesco Menichetti, Veli-Jukka Anttila, et al.
Antiviral Therapy|October 26, 2011
Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipientsIsabel Ruiz-Camps, Oscar Len, Rafael de la Cámara, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2015
Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trialJulian Torre-Cisneros, Rafael San-Juan, Clara M Rosso-Fernández, et al.
The Journal of Allergy and Clinical Immunology|July 26, 2020
IL-6-based mortality risk model for hospitalized patients with COVID-19Rocio Laguna-Goya, Alberto Utrero-Rico, Paloma Talayero, et al.
The Lancet. Infectious Diseases|September 8, 2023
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patientsBenjamin W Teh, Malgorzata Mikulska, Dina Averbuch, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 1, 2017
Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistanceRubén López-Aladid, Alba Guiu, Gemma Sanclemente, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|September 22, 2010
Safety and efficacy of moxifloxacin monotherapy for treatment of orthopedic implant-related staphylococcal infectionsRafael San Juan, Ana Garcia-Reyne, Pedro Caba, et al.
Urology|February 19, 2008
Incisional surgical site infection in kidney transplantationAntonio Ramos, Angel Asensio, Elena Muñez, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 29, 2007
Staphylococcus aureus poststernotomy mediastinitis: description of two distinct acquisition pathways with different potential preventive approachesRafael San Juan, Fernando Chaves, Maria Jesus López Gude, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 24, 2024
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with "difficult to treat" Gram-negative bacteriaCecilia Bonazzetti, Matteo Rinaldi, Federica Cosentino, et al.
The Lancet. Infectious Diseases|December 24, 2017
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trialBenoit Guery, Francesco Menichetti, Veli-Jukka Anttila, et al.
Antiviral Therapy|October 26, 2011
Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipientsIsabel Ruiz-Camps, Oscar Len, Rafael de la Cámara, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2015
Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trialJulian Torre-Cisneros, Rafael San-Juan, Clara M Rosso-Fernández, et al.
The Journal of Allergy and Clinical Immunology|July 26, 2020
IL-6-based mortality risk model for hospitalized patients with COVID-19Rocio Laguna-Goya, Alberto Utrero-Rico, Paloma Talayero, et al.
The Lancet. Infectious Diseases|September 8, 2023
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patientsBenjamin W Teh, Malgorzata Mikulska, Dina Averbuch, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 1, 2017
Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistanceRubén López-Aladid, Alba Guiu, Gemma Sanclemente, et al.
Pageof 3